Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.0001
0.0000
(0.00%)
As of March 3 at 3:00:00 PM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Total Revenue
313
310
8
285
Cost of Revenue
197
197
--
--
Gross Profit
116
113
8
285
Operating Expense
15,486
14,770
12,932
17,199
Operating Income
-15,370
-14,657
-12,924
-16,914
Other Income Expense
4,828
3,393
-1,483
862
Pretax Income
-10,542
-11,264
-14,407
-16,052
Net Income Common Stockholders
-10,542
-11,264
-14,407
-16,052
Diluted NI Available to Com Stockholders
-10,542
-11,264
-14,407
-16,052
Basic EPS
-1.09
-3.41
-1.61
-1.80
Diluted EPS
-1.09
-3.41
-1.61
-1.80
Basic Average Shares
9,674.4960
3,302.8180
8,936.4480
8,936.4480
Diluted Average Shares
9,674.4960
3,302.8180
8,936.4480
8,936.4480
Total Operating Income as Reported
-15,370
-14,657
-12,924
-16,914
Total Expenses
15,683
14,967
12,932
17,199
Net Income from Continuing & Discontinued Operation
-10,542
-11,264
-14,407
-16,052
Normalized Income
-14,099
-16,214
-11,892
-16,052
EBIT
-15,370
-14,657
-12,924
-16,914
EBITDA
-15,116
-14,400
-12,601
-16,588
Reconciled Cost of Revenue
197
197
--
--
Reconciled Depreciation
254
257
323
326
Net Income from Continuing Operation Net Minority Interest
-10,542
-11,264
-14,407
-16,052
Total Unusual Items Excluding Goodwill
3,557
4,950
-2,515
--
Total Unusual Items
3,557
4,950
-2,515
--
Normalized EBITDA
-18,673
-19,350
-10,086
-16,588
12/31/2021 - 10/17/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ETBI Eastgate Biotech Corp.
0.0045
+4,400.01%
MDCLF MedinCell S.A.
6.98
0.00%
ATHXQ Athersys, Inc.
0.0000
0.00%
HOPHF Hemogenyx Pharmaceuticals Plc
1.2400
0.00%
ELDN Eledon Pharmaceuticals, Inc.
3.8300
-4.37%
DMAC DiaMedica Therapeutics Inc.
5.88
-5.31%
SCPX Scorpius Holdings, Inc.
0.1452
-9.19%
RZLT Rezolute, Inc.
3.9900
-3.62%
PULM Pulmatrix, Inc.
7.08
-9.11%
ATHE Alterity Therapeutics Limited
3.5700
-1.92%